DWTX logo

Dogwood Therapeutics, Inc.

DWTX
Healthcare|Biotechnology|US
$1.28
+0.24 (+23.08%)
DCF Value
$0.69
Cash / Share
$144984.79

Ownership Breakdown

25.9%
Float
38.2M
Shares Outstanding
9.9M
Float Shares

Major Holders (5)

Combined: 170.4%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
CK Life Sciences Int'l., (Holdings) Inc.Corporation75.20%28,763,331Oct 27, 202613D/G
Sealbond LimitedCorporation67.80%25,920,693Oct 27, 202613D/G
Steven BoydHC, IN9.99%3,384,798Aug 14, 202613D/G
Armistice Capital, LLCIA, OO9.99%3,384,798Aug 14, 202613D/G
Conjoint Inc.Corporation7.40%2,842,638Oct 27, 202613D/G

Insider Trades (39)

Last 4 quarters: 30,106,648 acquired · 2,445.359 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Sealbond Ltddirector, 10 percent owner, other: See RemarksOct 26, 2026AWARD4,098,360$1.22$5.0MForm 4
De La Rosa AbeldirectorJun 16, 2026AWARD16,800$1.50$25.2KForm 4
Thomas John CdirectorJun 16, 2026AWARD16,800$1.50$25.2KForm 4
Whitley Richard JamesdirectorJun 16, 2026AWARD16,800$1.50$25.2KForm 4
Keefer David RdirectorJun 16, 2026AWARD16,800$1.50$25.2KForm 4
Grosswald RalphSVP OF OPERATIONSMar 5, 2026AWARD82,500$2.86$235.9KForm 4
Walsh AngelaChief Financial OfficerMar 5, 2026AWARD82,500$2.86$235.9KForm 4
Gendreau Roger MichaelCHIEF MEDICAL OFFICERMar 5, 2026AWARD82,500$2.86$235.9KForm 4
Duncan Gregory Scottdirector, officer: CHIEF EXECUTIVE OFFICERMar 5, 2026AWARD330,000$2.86$943.8KForm 4
Duncan Gregory Scottdirector, officer: CHIEF EXECUTIVE OFFICERDec 4, 2025AWARD460,000$6.14$2.8MForm 4
Walsh AngelaChief Financial OfficerDec 4, 2025AWARD150,000$6.14$921.0KForm 4
Grosswald RalphSVP OF OPERATIONSDec 4, 2025AWARD150,000$6.14$921.0KForm 4
Gendreau Roger MichaelCHIEF MEDICAL OFFICERDec 4, 2025AWARD150,000$6.14$921.0KForm 4
Sealbond Ltddirector, 10 percent owner, other: See RemarksNov 21, 2025CONVERSION21,610,950$0.00$2.2KForm 4
Sealbond Ltddirector, 10 percent owner, other: See RemarksNov 21, 2025CONVERSION2,842,638$0.00$284.26Form 4
Sealbond Ltddirector, 10 percent owner, other: See RemarksNov 21, 2025CONVERSION2,161.095——Form 4
Sealbond Ltddirector, 10 percent owner, other: See RemarksNov 21, 2025CONVERSION284.264——Form 4
Gendreau Roger MichaelCHIEF MEDICAL OFFICERJun 27, 2025AWARD12,075$4.71$56.9KForm 4
Whitley Richard JamesdirectorJun 27, 2025AWARD2,362$4.71$11.1KForm 4
Grosswald RalphSVP OF OPERATIONSJun 27, 2025AWARD12,075$4.71$56.9KForm 4
Thomas John CdirectorJun 27, 2025AWARD2,362$4.71$11.1KForm 4
Duncan Gregory Scottdirector, officer: CHIEF EXECUTIVE OFFICERJun 27, 2025AWARD40,000$4.71$188.4KForm 4
Keefer David RdirectorJun 27, 2025AWARD2,362$4.71$11.1KForm 4
Walsh AngelaChief Financial OfficerJun 27, 2025AWARD12,075$4.71$56.9KForm 4
De La Rosa AbeldirectorJun 27, 2025AWARD2,362$4.71$11.1KForm 4
Whitley Richard JamesdirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
Whitley Richard JamesdirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
Keefer David RdirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
Keefer David RdirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
Thomas John CdirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
Thomas John CdirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
De La Rosa AbeldirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
De La Rosa AbeldirectorJun 18, 2025AWARD210$4.80$1.0KForm 4
Conjoint Inc.director, 10 percent owner, other: See RemarksMar 12, 2025OTHER2,842,638——Form 4
CK Life Sciences Intl (Holdings) Incdirector, 10 percent owner, other: See RemarksMar 12, 2025AWARD284.264——Form 4
Yu Ying Choi Alan Abeldirector: Oct 7, 2024OTHER0——Form 4
Toh Kean Meng Melvindirector: Oct 7, 2024OTHER0——Form 4
Sealbond Ltd10 percent ownerOct 7, 2024OTHER0——Form 4
Sealbond Ltd10 percent ownerOct 7, 2024OTHER21,083,854——Form 4